J Med Microbiol 52 (2003), 711-714; DOI: 10.1099/jmm.0.05210-0
© 2003 Society for General Microbiology
ISSN 0022-2615
Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus
John E. Gustafson1,
Frances G. O'Brien2,
Geoffrey W. Coombs2,
Mary J. Malkowski2,
Warren B. Grubb2,
Richard F. Pfeltz3,
and
Brian J. Wilkinson3
1Department of Biology, New Mexico State University, Las Cruces, NM 88003-8001, USA 2Gram-positive Bacteria Typing and Research Unit, Curtin University of Technology, and Royal Perth Hospital, Perth 6845, Western Australia 3Microbiology Group, Department of Biological Sciences, Illinois State University, Normal, IL 61790-4120, USA
Correspondence John E. Gustafson jgustafs{at}nmsu.edu
Received February 3, 2003
Accepted April 16, 2003
 |
Abstract
|
|---|
The ability of phage-typing and SmaI chromosomal RFLPs to conclude appropriate strain relatedness between a collection of 12 well-characterized in vitro-selected vancomycin-intermediate Staphylococcus aureus (VISA) strains and their seven vancomycin-susceptible parent strains is reported. Generally, no SmaI RFLP alterations were observed in VISA strains when they were compared with their respective parent strains, and clonal relationships between isogenic strains were clearly evident. Unlike the SmaI RFLP results, parent strains and VISA derivatives generally did not share similar phage-typing profiles. Depending on the phage set investigated, some VISA strains even became untypable by this method. Loss of phage infectivity is probably due to cell wall (phage receptor) alterations that are expressed by the VISA strains investigated. Collectively, these findings indicate that inappropriate relationships between VISA and vancomycin-susceptible parents might be drawn if only phage-typing and antibiotic susceptibility are utilized to determine epidemiological relationships.
Present address: BD Diagnostic Systems, 7 Loveton Circle, Sparks, MD 21152, USA.
Abbreviations: MRSA, methicillin-resistant S. aureus; VISA, vancomycin-intermediate S. aureus; VRSA, vancomycin-resistant S. aureus.
 |
Introduction
|
|---|
Analysis of SmaI chromosomal RFLPs produced using PFGE is very effective in tracking Staphylococcus aureus clones (Jorgensen et al., 1996; O'Brien et al., 1999; Simor et al., 2002). Phage typing is also used to track outbreak, epidemic and community strains of S. aureus effectively (Blair & Williams, 1961; O'Brien et al., 1999; O'Neill et al., 2001). While phage typing is often valuable in discerning strain relationships quickly and inexpensively, the technique is not always helpful, since non-typable S. aureus strains exist (Blair & Williams, 1961; Andrasevic et al., 1999; Tambic et al., 1997).
The glycopeptide antibiotic vancomycin is still the major drug of choice for treatment of severe disease caused by infection with methicillin-resistant S. aureus (MRSA). Since 1997, vancomycin-intermediate S. aureus (VISA) have become an emerging clinical reality (Hiramatsu et al., 1997a). Vancomycin-intermediate expression in S. aureus is mediated by chromosomal mutation(s) (Avison et al., 2002; Pfeltz et al., 2000; Sakoulas et al., 2002; Walsh & Howe, 2002) and is not due to horizontal gene transfer of vancomycin-resistance determinants (van) from organisms such as the vancomycin-resistant enterococci. VISA strains harbour a chromosomal mutation(s) that leads to alterations in cell-wall synthesis and structure, which are thought to impart resistance by sequestering glycopeptide molecules away from their target (for review, see Walsh & Howe, 2002). PFGE and SmaI chromosomal RFLP analysis have been used to demonstrate that VISA can disseminate in a clonal fashion (Chesneau et al., 2000; Hiramatsu et al. 1997b; Kim et al., 2002). Two reports have now appeared on high-level vancomycin-resistant S. aureus (VRSA) that have acquired the enterococcal vanA determinant (Miller et al., 2002; Sievert et al., 2002). Outbreaks with VISA or VRSA have not yet become a common occurrence.
We now report on the ability of phage typing and PFGE to conclude appropriate strain relatedness between a collection of 12 in vitro-selected VISA and their seven vancomycin-susceptible parents.
 |
Methods
|
|---|
Strains.
The strains analysed represent various genetic backgrounds and methicillin resistance levels and their isogenic in vitro step-selected VISA derivatives (Pfeltz et al., 2000). The subscript V in a strain designation refers to a vancomycin-intermediate derivative (e.g. BB270V5) of a susceptible parent strain (e.g. BB270), and the number associated with the subscript V (such as V5) refers to the vancomycin concentration at which the strain was maintained directly following VISA phenotype selection (e.g. 5 µg ml-1 for BB270V5) and not the actual vancomycin MIC (Pfeltz et al., 2000). The MICs of the strains for vancomycin, teicoplanin and oxacillin and other characteristics of these strains were described by Pfeltz et al. (2000).
Phage typing and PFGE.
Phage typing, performed on strains passaged in antibiotic-free medium, and PFGE of SmaI chromosomal digests were performed as described previously (Blair & Williams, 1961; O'Brien et al., 1999). Chromosomal banding patterns were scanned with a Flour-S MultImager and analysed by Multi-Analyst/PC (Bio-Rad).
 |
Results and Discussion
|
|---|
SmaI chromosomal RFLPs of the isogenic parents (BB255, BB270, SH108, BB399, 13136p-m+, BB568 and COL) and in vitro-selected VISA strains (BB255V3, BB270V5, BB270V15, SH108V5, BB399V5, BB399V12, 13136p-m+V5, 13136p- m+V20, BB568V5, BB568V15, COLV5 and COLV10) and a dendrogram generated from these RFLPs are shown in Fig. 1. It should be noted that strain BB270 is a methicillin-resistant transductant of BB255, and strains BB568 and COL are isogenic (Pfeltz et al., 2000); therefore, as expected, these strain pairs cluster together (Fig. 1). SmaI restriction profiles also revealed that, with the exception of VISA strain BB399V12, no significant alterations occurred in the SmaI chromosomal RFLPs of most strains (BB255, BB270, SH108, 13136p-m+, BB568 and COL) as they were step-selected to become vancomycin-intermediate. These data confirm that major genetic alterations are not required for S. aureus to develop the VISA phenotype. In addition, clonal relationships between the collection of in vitro-selected VISA mutants and isogenic parent strains are clearly evident. Other investigators have also demonstrated that in-vitro-selected VISA retain parental SmaI RFLP patterns (Schaaff et al., 2002). SmaI chromosomal RFLPs are also similar between VISA that arise from vancomycin-susceptible strains during vancomycin therapy in a single patient (Rotun et al., 1999; Sieradski et al., 1999a; Smith et al., 1999).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 1. Cartoon of SmaI-macrorestricted chromosomal RFLPs of S. aureus strains investigated and dendrogram to demonstrate percentage relatedness. , Band alterations between BB399 and BB399V12.
|
|
A 300 kb SmaI fragment present in parent strain BB399 has been replaced by a 275 kb fragment in BB399V12 (Fig. 1), indicating the loss of
25 kb, which actually allowed BB399V12 to cluster with COL and BB568. Altered SmaI RFLP patterns have been reported to occur within in vitro-selected VISA strains (Riepert et al., 2003). These alterations have been attributed to loss of the methicillin-resistance determinant (mec) as well as other genes (Riepert et al., 2003; Sieradzki et al., 1999b). BB399V12, however, maintains high-level methicillin resistance, similar to parent BB399 (Pfeltz et al., 2000), indicating that the former has not lost mec. SmaI RFLP alterations can result from the loss of a prophage (Smeltzer et al., 1994) and, perhaps, during the selection for the VISA phenotype in BB399V12, a prophage excised and was lost.
Unlike the SmaI RFLP results, parent strains and VISA derivatives generally did not share similar phage-typing profiles using the international basic phage set (IBPS), the international MRSA phage set (IMRSA) or the Australian MRSA phage set (AMRSA) (Table 1). When the IBPS was used, all VISA derivatives demonstrated altered phage types when compared with their respective parent strains. VISA mutant 13136p-m+V5 even became non-typable by this phage set. Typing with IMRSA revealed that isogenic strain sets BB255 and BB255V3 and BB568 and BB568V5 had the same phage types, while strain 13136p-m+ and its VISA mutants were non-typable by this phage set. All other VISA strains exhibited altered IMRSA types compared with their respective parent strains, and SH108V5 became untypable. Typing with AMRSA revealed that the BB255 and BB568 strain sets all had identical phage types, as did COL and its VISA derivative COLV5. All other VISA mutants demonstrated altered AMRSA types compared with their respective parent strains, and BB399V5 became untypable. Other studies have also shown alterations in phage-typing patterns following in vitro acquisition of a VISA phenotype in S. aureus (Daum et al., 1992; Schaaff et al., 2002).
Phage infection can be prevented in Gram-positive bacteria as a result of adsorption inhibition (Chatterjee, 1969; Tran et al., 1999; Wilkinson & Holmes, 1979), restriction modification systems (Kong & Josephsen, 2002), DNA injection-blocking systems (McGrath et al., 2002), lysogenization (Beard-Pegler & Vickery, 1985) and abortive infection systems (Dai et al., 2001). We showed that the in vitro VISA investigated demonstrated minimal to no alteration in SmaI RFLPs compared with parent strains; however, alterations in phage types were common. This latter finding is probably due to modifications of phage cell-wall receptors that result from alterations in cell-wall physiology that are expressed by the VISA strains investigated (Pfeltz et al., 2000). Collectively, these findings indicate that inappropriate relationships between VISA and vancomycin-susceptible parents might be drawn if only phage-typing is utilized to determine epidemiological relationships. This might be especially true in situations where VISA arise within a single infected patient being treated with vancomycin, as has previously been reported to occur (Rotun et al., 1999; Sieradski et al., 1999a; Smith et al., 1999). Recognizing vancomycin- susceptible parent strains may be of clinical importance, since some S. aureus strains can mutate to become VISA with greater ease compared with other strains (Pfeltz et al., 2000; Schaaff et al., 2002), and the presence of these strains may therefore indicate a unique threat.
 |
Acknowledgements
|
|---|
J. E. G. acknowledges support from NIH grant R15 AI9919701A1 and B. J. W. acknowledges support from NIH grant R15 AI049964. W. B. G. acknowledges a grant from the Australian NHMRC.
 |
References
|
|---|
Andrasevic, A. T., Power, E. G., Anthony, R. M., Kalenic, S. & French, G. L. (1999). Failure of bacteriophage typing to detect an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus (MRSA) in Zagreb subsequently identified by random amplification of polymorphic DNA (RAPD) and pulsed-field gel electrophoresis (PFGE). Clin Microbiol Infect 5, 634642.[Medline]
Avison, M. B., Bennett, P. M., Howe, R. A. & Walsh, T. R. (2002). Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50. J Antimicrob Chemother 49, 255260.[Abstract/Free Full Text]
Beard-Pegler, M. A. & Vickery, A. M. (1985). Lysogenicity of methicillin-resistant strains of Staphylococcus aureus. J Med Microbiol 20, 147155.[Abstract]
Blair, J. E. & Williams, R. E. O. (1961). Phage typing of staphylococci. Bull W H O 24, 771784.
Chatterjee, A. N. (1969). Use of bacteriophage-resistant mutants to study the nature of bacteriophage receptor site of Staphylococcus aureus. J Bacteriol 98, 519527.[Abstract/Free Full Text]
Chesneau, O., Morvan, A. & El Solh, N. (2000). Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. J Antimicrob Chemother 45, 887890.[Abstract/Free Full Text]
Dai, G., Su, P., Allison, G. E., Geller, B. L., Zhu, P., Kim, W. S. & Dunn, N. W. (2001). Molecular characterization of a new abortive infection system (AbiU) from Lactococcus lactis LL511. Appl Environ Microbiol 67, 52255232.[Abstract/Free Full Text]
Daum, R. S., Gupta, S., Sabbagh, R. & Milewski, W. M. (1992). Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J Infect Dis 166, 10661072.[Medline]
Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover, F. C. (1997a). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40, 135136.[Free Full Text]
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y. & Kobayashi, I. (1997b). Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350, 16701673.[CrossRef][Medline]
Jorgensen, M., Givney, R., Pegler, M., Vickery, A. & Funnell, G. (1996). Typing multidrug-resistant Staphylococcus aureus: conflicting epidemiological data produced by genotypic and phenotypic methods clarified by phylogenetic analysis. J Clin Microbiol 34, 398403.[Abstract]
Kim, M. N., Hwang, S. H., Pyo, Y. J., Mun, H. M. & Pai, C. H. (2002). Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol 40, 13761380.[Abstract/Free Full Text]
Kong, J. & Josephsen, J. (2002). The ability of the plasmid-encoded restriction and modification system LlaBII to protect Lactococcus lactis against bacteriophages. Lett Appl Microbiol 34, 249253.[CrossRef][Medline]
McGrath, S., Fitzgerald, G. F. & van Sinderen, D. (2002). Identification and characterization of phage-resistance genes in temperate lactococcal bacteriophages. Mol Microbiol 43, 509520.[CrossRef][Medline]
Miller, D., Urdaneta, V. & Weltman, A. (2002). Public Health Dispatch: vancomycin-resistant Staphylococcus aureus Pennsylvania, 2002. MMWR 51, 902. 902.[Medline]
O'Brien, F. G., Pearman, J. W., Gracey, M., Riley, T. V. & Grubb, W. B. (1999). Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 37, 28582862.[Abstract/Free Full Text]
O'Neill, G. L., Murchan, S., Gil-Setas, A. & Aucken, H. M. (2001). Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15). J Clin Microbiol 39, 15401548.[Abstract/Free Full Text]
Pfeltz, R. F., Singh, V. K., Schmidt, J. L., Batten, M. A., Baranyk, C. S., Nadakavukaren, M. J., Jayaswal, R. K. & Wilkinson, B. J. (2000). Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds. Antimicrob Agents Chemother 44, 294303.[Abstract/Free Full Text]
Riepert, A., Ehlert, K., Kast, T. & Bierbaum, G. (2003). Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. Antimicrob Agents Chemother 47, 568576.[Abstract/Free Full Text]
Rotun, S. S., McMath, V., Schoonmaker, D. J., Maupin, P. S., Tenover, F. C., Hill, B. C. & Ackman, D. M. (1999). Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 5, 147149.[Medline]
Sakoulas, G., Eliopoulos, G. M., Moellering, R. C., Jr, Wennersten, C., Venkataraman, L., Novick, R. P. & Gold, H. S. (2002). Accessory gene regulator (agr) locus of geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 46, 14921502.[Abstract/Free Full Text]
Schaaff, F., Reipert, A. & Bierbaum, G. (2002). An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 46, 35403548.[Abstract/Free Full Text]
Sieradski, K., Roberts, R. B., Haber, S. W. & Tomasz, A. (1999a). The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 340, 517523.[Free Full Text]
Sieradzki, K., Wu, S. W. & Tomasz, A. (1999b). Inactivation of the methicillin resistance gene mecA in vancomycin-resistant Staphylococcus aureus. Microb Drug Resist 5, 253257.[Medline]
Sievert, D. M., Boulton, M. L., Stoltman, G. & 11 other authors (2002). Staphylococcus aureus resistant to vancomycin United States, 2002. MMWR 51, 565567.[Medline]
Simor, A. E., Ofner-Agostini, M., Bryce, E., McGeer, A., Paton, S. & Mulvey, M. R. (2002). Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance. J Infect Dis 186, 652660.[CrossRef][Medline]
Smeltzer, M. S., Hart, M. E. & Iandolo, J. J. (1994). The effect of lysogeny on the genomic organization of Staphylococcus aureus. Gene 138, 5157.[CrossRef][Medline]
Smith, T. L., Pearson, M. L., Wilcox, K. R. & 8 other authors (1999). Emergence of vancomycin resistance in Staphylococcus aureus.Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 340, 493501.[Abstract/Free Full Text]
Tambic, A., Power, E. G., Talsania, H., Anthony, R. M. & French, G. L. (1997). Analysis of an outbreak of non-phage-typeable methicillin-resistant Staphylococcus aureus by using a randomly amplified polymorphic DNA assay. J Clin Microbiol 35, 30923097.[Abstract]
Tran, H. L., Fiedler, F., Hodgson, D. A. & Kathariou, S. (1999). Transposon-induced mutations in two loci of Listeria monocytogenes serotype 1/2a result in phage resistance and lack of N-acetylglucosamine in the teichoic acid of the cell wall. Appl Environ Microbiol 65, 47934798.[Abstract/Free Full Text]
Walsh, T. R. & Howe, R. A. (2002). The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol 56, 657675.[CrossRef][Medline]
Wilkinson, B. J. & Holmes, K. M. (1979). Staphylococcus aureus cell surface: capsule as a barrier to bacteriophage adsorption. Infect Immun 23, 549552.[Abstract/Free Full Text]